The Next Generation of CAR-T and AI-Driven Discovery

Episode 31 of The Conversational Flow Podcast dives deep into some of the most exciting developments currently shaping the future of cell therapy, flow cytometry, and AI-driven drug development. Our hosts, Brian and Adam, discuss major advances in allogeneic and in vivo CAR-T therapies, including how new manufacturing platforms and delivery methods could dramatically reduce treatment costs while expanding patient access. The conversation also explores how AI is accelerating pharmaceutical R&a...